Free Trial

Rapid Micro Biosystems (RPID) Competitors

Rapid Micro Biosystems logo
$1.97 -0.04 (-1.99%)
Closing price 04:00 PM Eastern
Extended Trading
$1.97 0.00 (0.00%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

RPID vs. NAUT, PRE, MASS, SENS, and QSI

Should you buy Rapid Micro Biosystems stock or one of its competitors? MarketBeat compares Rapid Micro Biosystems with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Rapid Micro Biosystems include Nautilus Biotechnology (NAUT), Prenetics Global (PRE), 908 Devices (MASS), Senseonics Holdings, Inc. Common Stock (SENS), and Quantum-Si (QSI). These companies are all part of the "measuring and control equipment" industry.

How does Rapid Micro Biosystems compare to Nautilus Biotechnology?

Rapid Micro Biosystems (NASDAQ:RPID) and Nautilus Biotechnology (NASDAQ:NAUT) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, earnings, profitability, risk, media sentiment and valuation.

Rapid Micro Biosystems has a beta of 1.45, suggesting that its stock price is 45% more volatile than the broader market. Comparatively, Nautilus Biotechnology has a beta of 0.75, suggesting that its stock price is 25% less volatile than the broader market.

Rapid Micro Biosystems has higher revenue and earnings than Nautilus Biotechnology. Nautilus Biotechnology is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rapid Micro Biosystems$33.59M2.71-$47.12M-$1.12N/A
Nautilus BiotechnologyN/AN/A-$59M-$0.46N/A

In the previous week, Rapid Micro Biosystems had 4 more articles in the media than Nautilus Biotechnology. MarketBeat recorded 5 mentions for Rapid Micro Biosystems and 1 mentions for Nautilus Biotechnology. Nautilus Biotechnology's average media sentiment score of 1.89 beat Rapid Micro Biosystems' score of 0.23 indicating that Nautilus Biotechnology is being referred to more favorably in the news media.

Company Overall Sentiment
Rapid Micro Biosystems Neutral
Nautilus Biotechnology Very Positive

Rapid Micro Biosystems currently has a consensus price target of $6.00, indicating a potential upside of 204.57%. Nautilus Biotechnology has a consensus price target of $4.00, indicating a potential upside of 44.40%. Given Rapid Micro Biosystems' stronger consensus rating and higher possible upside, equities research analysts plainly believe Rapid Micro Biosystems is more favorable than Nautilus Biotechnology.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Rapid Micro Biosystems
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Nautilus Biotechnology
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

52.6% of Rapid Micro Biosystems shares are owned by institutional investors. Comparatively, 50.7% of Nautilus Biotechnology shares are owned by institutional investors. 12.7% of Rapid Micro Biosystems shares are owned by company insiders. Comparatively, 41.1% of Nautilus Biotechnology shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Nautilus Biotechnology has a net margin of 0.00% compared to Rapid Micro Biosystems' net margin of -145.81%. Nautilus Biotechnology's return on equity of -35.04% beat Rapid Micro Biosystems' return on equity.

Company Net Margins Return on Equity Return on Assets
Rapid Micro Biosystems-145.81% -131.52% -67.48%
Nautilus Biotechnology N/A -35.04%-29.16%

Summary

Rapid Micro Biosystems beats Nautilus Biotechnology on 9 of the 15 factors compared between the two stocks.

How does Rapid Micro Biosystems compare to Prenetics Global?

Rapid Micro Biosystems (NASDAQ:RPID) and Prenetics Global (NASDAQ:PRE) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, earnings, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability.

Prenetics Global has higher revenue and earnings than Rapid Micro Biosystems. Prenetics Global is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rapid Micro Biosystems$33.59M2.71-$47.12M-$1.12N/A
Prenetics Global$92.39M3.72-$37.71M-$4.02N/A

Rapid Micro Biosystems has a beta of 1.45, meaning that its share price is 45% more volatile than the broader market. Comparatively, Prenetics Global has a beta of 0.24, meaning that its share price is 76% less volatile than the broader market.

52.6% of Rapid Micro Biosystems shares are held by institutional investors. Comparatively, 25.0% of Prenetics Global shares are held by institutional investors. 12.7% of Rapid Micro Biosystems shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Prenetics Global has a net margin of -61.33% compared to Rapid Micro Biosystems' net margin of -145.81%. Prenetics Global's return on equity of -19.61% beat Rapid Micro Biosystems' return on equity.

Company Net Margins Return on Equity Return on Assets
Rapid Micro Biosystems-145.81% -131.52% -67.48%
Prenetics Global -61.33%-19.61%-15.33%

Rapid Micro Biosystems currently has a consensus target price of $6.00, suggesting a potential upside of 204.57%. Prenetics Global has a consensus target price of $32.33, suggesting a potential upside of 58.57%. Given Rapid Micro Biosystems' higher probable upside, equities research analysts plainly believe Rapid Micro Biosystems is more favorable than Prenetics Global.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Rapid Micro Biosystems
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Prenetics Global
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

In the previous week, Rapid Micro Biosystems had 3 more articles in the media than Prenetics Global. MarketBeat recorded 5 mentions for Rapid Micro Biosystems and 2 mentions for Prenetics Global. Prenetics Global's average media sentiment score of 0.94 beat Rapid Micro Biosystems' score of 0.23 indicating that Prenetics Global is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Rapid Micro Biosystems
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Prenetics Global
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Prenetics Global beats Rapid Micro Biosystems on 9 of the 16 factors compared between the two stocks.

How does Rapid Micro Biosystems compare to 908 Devices?

908 Devices (NASDAQ:MASS) and Rapid Micro Biosystems (NASDAQ:RPID) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends.

88.1% of 908 Devices shares are owned by institutional investors. Comparatively, 52.6% of Rapid Micro Biosystems shares are owned by institutional investors. 28.2% of 908 Devices shares are owned by company insiders. Comparatively, 12.7% of Rapid Micro Biosystems shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

908 Devices currently has a consensus target price of $12.00, suggesting a potential upside of 39.05%. Rapid Micro Biosystems has a consensus target price of $6.00, suggesting a potential upside of 204.57%. Given Rapid Micro Biosystems' stronger consensus rating and higher probable upside, analysts clearly believe Rapid Micro Biosystems is more favorable than 908 Devices.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
908 Devices
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Rapid Micro Biosystems
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

908 Devices has higher revenue and earnings than Rapid Micro Biosystems. 908 Devices is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
908 Devices$56.20M5.81$19.49M-$1.00N/A
Rapid Micro Biosystems$33.59M2.71-$47.12M-$1.12N/A

908 Devices has a beta of 0.63, meaning that its stock price is 37% less volatile than the broader market. Comparatively, Rapid Micro Biosystems has a beta of 1.45, meaning that its stock price is 45% more volatile than the broader market.

908 Devices has a net margin of -62.40% compared to Rapid Micro Biosystems' net margin of -145.81%. 908 Devices' return on equity of -14.03% beat Rapid Micro Biosystems' return on equity.

Company Net Margins Return on Equity Return on Assets
908 Devices-62.40% -14.03% -10.40%
Rapid Micro Biosystems -145.81%-131.52%-67.48%

In the previous week, 908 Devices had 2 more articles in the media than Rapid Micro Biosystems. MarketBeat recorded 7 mentions for 908 Devices and 5 mentions for Rapid Micro Biosystems. Rapid Micro Biosystems' average media sentiment score of 0.23 beat 908 Devices' score of -0.04 indicating that Rapid Micro Biosystems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
908 Devices
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Rapid Micro Biosystems
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

908 Devices beats Rapid Micro Biosystems on 10 of the 16 factors compared between the two stocks.

How does Rapid Micro Biosystems compare to Senseonics Holdings, Inc. Common Stock?

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) and Rapid Micro Biosystems (NASDAQ:RPID) are both small-cap measuring and control equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, valuation and dividends.

Senseonics Holdings, Inc. Common Stock has a beta of 1.05, indicating that its stock price is 5% more volatile than the broader market. Comparatively, Rapid Micro Biosystems has a beta of 1.45, indicating that its stock price is 45% more volatile than the broader market.

12.4% of Senseonics Holdings, Inc. Common Stock shares are owned by institutional investors. Comparatively, 52.6% of Rapid Micro Biosystems shares are owned by institutional investors. 4.7% of Senseonics Holdings, Inc. Common Stock shares are owned by company insiders. Comparatively, 12.7% of Rapid Micro Biosystems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Rapid Micro Biosystems had 2 more articles in the media than Senseonics Holdings, Inc. Common Stock. MarketBeat recorded 5 mentions for Rapid Micro Biosystems and 3 mentions for Senseonics Holdings, Inc. Common Stock. Senseonics Holdings, Inc. Common Stock's average media sentiment score of 1.61 beat Rapid Micro Biosystems' score of 0.23 indicating that Senseonics Holdings, Inc. Common Stock is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Senseonics Holdings, Inc. Common Stock
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Rapid Micro Biosystems
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Rapid Micro Biosystems has a net margin of -145.81% compared to Senseonics Holdings, Inc. Common Stock's net margin of -213.87%. Senseonics Holdings, Inc. Common Stock's return on equity of -129.97% beat Rapid Micro Biosystems' return on equity.

Company Net Margins Return on Equity Return on Assets
Senseonics Holdings, Inc. Common Stock-213.87% -129.97% -67.14%
Rapid Micro Biosystems -145.81%-131.52%-67.48%

Rapid Micro Biosystems has lower revenue, but higher earnings than Senseonics Holdings, Inc. Common Stock. Senseonics Holdings, Inc. Common Stock is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Senseonics Holdings, Inc. Common Stock$35.26M8.11-$69.11M-$2.00N/A
Rapid Micro Biosystems$33.59M2.71-$47.12M-$1.12N/A

Senseonics Holdings, Inc. Common Stock currently has a consensus target price of $17.00, suggesting a potential upside of 148.54%. Rapid Micro Biosystems has a consensus target price of $6.00, suggesting a potential upside of 204.57%. Given Rapid Micro Biosystems' higher possible upside, analysts clearly believe Rapid Micro Biosystems is more favorable than Senseonics Holdings, Inc. Common Stock.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Senseonics Holdings, Inc. Common Stock
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.67
Rapid Micro Biosystems
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

Summary

Rapid Micro Biosystems beats Senseonics Holdings, Inc. Common Stock on 9 of the 17 factors compared between the two stocks.

How does Rapid Micro Biosystems compare to Quantum-Si?

Rapid Micro Biosystems (NASDAQ:RPID) and Quantum-Si (NASDAQ:QSI) are both small-cap measuring and control equipment companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, valuation, analyst recommendations, media sentiment, profitability and earnings.

Rapid Micro Biosystems has a beta of 1.45, indicating that its share price is 45% more volatile than the broader market. Comparatively, Quantum-Si has a beta of 3.18, indicating that its share price is 218% more volatile than the broader market.

Rapid Micro Biosystems has higher revenue and earnings than Quantum-Si. Quantum-Si is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rapid Micro Biosystems$33.59M2.71-$47.12M-$1.12N/A
Quantum-Si$2.44M105.31-$101.34M-$0.51N/A

52.6% of Rapid Micro Biosystems shares are held by institutional investors. Comparatively, 39.9% of Quantum-Si shares are held by institutional investors. 12.7% of Rapid Micro Biosystems shares are held by company insiders. Comparatively, 22.0% of Quantum-Si shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Rapid Micro Biosystems has a net margin of -145.81% compared to Quantum-Si's net margin of -5,605.88%. Quantum-Si's return on equity of -47.35% beat Rapid Micro Biosystems' return on equity.

Company Net Margins Return on Equity Return on Assets
Rapid Micro Biosystems-145.81% -131.52% -67.48%
Quantum-Si -5,605.88%-47.35%-42.66%

Rapid Micro Biosystems presently has a consensus target price of $6.00, indicating a potential upside of 204.57%. Quantum-Si has a consensus target price of $1.00, indicating a potential downside of 15.25%. Given Rapid Micro Biosystems' stronger consensus rating and higher probable upside, research analysts clearly believe Rapid Micro Biosystems is more favorable than Quantum-Si.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Rapid Micro Biosystems
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Quantum-Si
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

In the previous week, Rapid Micro Biosystems had 4 more articles in the media than Quantum-Si. MarketBeat recorded 5 mentions for Rapid Micro Biosystems and 1 mentions for Quantum-Si. Quantum-Si's average media sentiment score of 1.87 beat Rapid Micro Biosystems' score of 0.23 indicating that Quantum-Si is being referred to more favorably in the news media.

Company Overall Sentiment
Rapid Micro Biosystems Neutral
Quantum-Si Very Positive

Summary

Rapid Micro Biosystems beats Quantum-Si on 9 of the 16 factors compared between the two stocks.

Get Rapid Micro Biosystems News Delivered to You Automatically

Sign up to receive the latest news and ratings for RPID and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RPID and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RPID vs. The Competition

MetricRapid Micro BiosystemsMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$90.96M$7.10B$6.31B$12.61B
Dividend YieldN/A1.21%2.68%5.22%
P/E Ratio-1.7645.1521.1326.68
Price / Sales2.7173.85546.66114.79
Price / CashN/A25.1527.4437.60
Price / Book2.637.329.956.88
Net Income-$47.12M$157.37M$3.56B$336.73M
7 Day Performance-3.90%3.48%2.12%4.20%
1 Month PerformanceN/AN/AN/A-0.08%
1 Year Performance-41.54%2.75%36.38%40.29%

Rapid Micro Biosystems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RPID
Rapid Micro Biosystems
3.646 of 5 stars
$1.97
-2.0%
$6.00
+204.6%
-40.4%$90.96M$33.59MN/A200
NAUT
Nautilus Biotechnology
3.5037 of 5 stars
$2.43
-4.3%
$4.00
+64.6%
+267.7%$322.78MN/AN/A130
PRE
Prenetics Global
3.0656 of 5 stars
$17.81
+6.2%
$32.33
+81.5%
+122.1%$282.98M$92.39MN/A1
MASS
908 Devices
1.853 of 5 stars
$7.92
+8.8%
$12.00
+51.5%
+46.0%$275.28M$56.20MN/A60
SENS
Senseonics Holdings, Inc. Common Stock
4.3487 of 5 stars
$6.43
+1.4%
$17.00
+164.4%
N/A$265.03M$35.26MN/A90

Related Companies and Tools


This page (NASDAQ:RPID) was last updated on 6/1/2026 by MarketBeat.com Staff.
From Our Partners